Production (Stage)
Dolby Laboratories, Inc.
DLB
$74.67
-$0.90-1.19%
NYSE
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.32B | 1.27B | 1.26B | 1.27B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32B | 1.32B | 1.27B | 1.26B | 1.27B |
| Cost of Revenue | 146.27M | 149.21M | 140.50M | 142.05M | 147.90M |
| Gross Profit | 1.17B | 1.17B | 1.13B | 1.12B | 1.12B |
| SG&A Expenses | 628.44M | 625.17M | 604.85M | 605.22M | 613.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.04B | 1.04B | 1.01B | 1.01B | 1.03B |
| Operating Income | 282.99M | 277.49M | 264.71M | 246.75M | 238.50M |
| Income Before Tax | 316.20M | 317.70M | 312.48M | 261.78M | 235.37M |
| Income Tax Expenses | 57.38M | 52.89M | 48.16M | 46.42M | 43.26M |
| Earnings from Continuing Operations | 258.82 | 264.81 | 264.32 | 215.36 | 192.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.19M | -2.14M | -2.49M | -2.92M | -1.71M |
| Net Income | 256.63M | 262.67M | 261.83M | 212.44M | 190.40M |
| EBIT | 282.99M | 277.49M | 264.71M | 246.75M | 238.50M |
| EBITDA | 366.56M | 357.54M | 340.27M | 322.08M | 316.56M |
| EPS Basic | 2.68 | 2.75 | 2.74 | 2.22 | 1.99 |
| Normalized Basic EPS | 2.12 | 2.09 | 2.06 | 1.93 | 1.85 |
| EPS Diluted | 2.64 | 2.71 | 2.70 | 2.19 | 1.96 |
| Normalized Diluted EPS | 2.09 | 2.06 | 2.03 | 1.90 | 1.82 |
| Average Basic Shares Outstanding | 383.03M | 382.41M | 382.18M | 382.48M | 382.45M |
| Average Diluted Shares Outstanding | 388.17M | 387.56M | 387.85M | 388.93M | 389.43M |
| Dividend Per Share | 1.29 | 1.26 | 1.23 | 1.20 | 1.17 |
| Payout Ratio | 47.03% | 44.76% | 43.76% | 52.62% | 57.21% |